Lene Noehr‐Jensen

The Hypoalgesic Effect of Oxycodone in Human Experimental Pain Models in Relation to the CYP2D6 Oxidation Polymorphism

Stine T. Zwisler, Thomas P. Enggaard, Lene Noehr‐Jensen et al. · Basic & Clinical Pharmacology & Toxicology · 2009 · 107 citations · Full text

The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the <i>OPRM1</i> and <i>ABCB1</i> genes

Stine T. Zwisler, Thomas P. Enggaard, Lene Noehr‐Jensen et al. · Fundamental and Clinical Pharmacology · 2009 · 97 citations

Pain Tolerance Thresholds, Pain Disorders, Acute Pain +21

Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker

Lene Noehr‐Jensen, Stine T. Zwisler, Fin Stolze Larsen et al. · European Journal of Clinical Pharmacology · 2009 · 44 citations

Optogenetics, Serotonergic Biomarker, Cyp2c19 Phenotypes +9

Escitalopram Is a Weak Inhibitor of the CYP2D6-Catalyzed O-Demethylation of (+)-Tramadol but Does Not Reduce the Hypoalgesic Effect in Experimental Pain

Lene Noehr‐Jensen, Stine T. Zwisler, Frank Larsen et al. · Clinical Pharmacology & Therapeutics · 2009 · 25 citations

Crossover Trial, Pain Medicine, Molecular Pain +21

The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers

Lene Noehr‐Jensen, Per Damkier, Tanja Busk Bidstrup et al. · European Journal of Clinical Pharmacology · 2006 · 23 citations

Pharmacological Study, Medicine, Healthy Volunteers +5